Strategies

Supreme Court Greenlights Insurer Challenges to Mass-Tort Bankruptcy Strategies

by

Washington — In a significant legal decision, the Supreme Court has empowered insurance companies to challenge the bankruptcy plans of companies facing mass-tort liabilities. This ruling could reshape the landscape of bankruptcy law and its interplay with mass-tort settlements. The case stems from a scenario where insurance firms disagreed with a bankruptcy plan proposed by a company beleaguered by numerous lawsuits. Traditionally, such financial restructurings seek to consolidate and settle debts, including potential lawsuit settlements. The justices held that insurers whose policies are implicated have the standing to contest these plans, a stance that might … Read more

Oklahoma’s Trust Law Overhaul Set to Transform Asset Protection and Management Strategies

by

Oklahoma City, OK — A landmark shift in trust and estate management is unfolding in Oklahoma as the state braces for the enactment of the Oklahoma Trust Reform Act of 2024. Signed into law on May 31 and poised for implementation starting November 1, this comprehensive suite of reforms places Oklahoma at the forefront of trust jurisdictions nationwide. Key components of this legislative overhaul include the Oklahoma Uniform Directed Trust Act and the Oklahoma Qualified Disposition in Trust Act, poised to offer unprecedented control and protection in asset management. The introduction of the Oklahoma Uniform … Read more

Exploring Legal Strategies for GLP-1 Weight-Loss Drug Manufacturers in the U.S. Mass Tort Arena

by

New York — As the rates of obesity continue to climb at an alarming rate worldwide, pharmaceutical companies have intensified their efforts in advancing medications targeted at weight management. Among these, glucagon-like peptide-1 receptor (GLP-1) weight-loss drugs have been gaining attention not just for their efficacy but also for the litigation challenges they may face. Historically, the American mass tort litigation landscape offers extensive insights that are invaluable for these manufacturers in navigating potential legal battles. In the U.S., mass tort claims have frequently emerged in the pharmaceutical sector, with companies often finding themselves entangled … Read more

Weight-Loss Drug Makers Navigate U.S. Litigation Landscape: Lessons from the Past and Strategies for Future Defense

by

Washington, D.C. – Amid booming sales, manufacturers of GLP-1 weight-loss drugs face a new challenge: the potential for mass tort litigation similar to what has historically rocked other sectors of the American pharmaceutical industry. Industry experts suggest that drawing lessons from past litigations could be key to these manufacturers not just surviving but thriving in an increasingly litigious environment. GLP-1, or glucagon-like peptide-1 receptor agonists, have gained attention not only for their effectiveness in obesity management but also for potential side effects which could become the focal point of legal battles. Given the aggressive nature … Read more